Abstract:The expression and methylation of p15INK4B gene and the expression of DNA methyltransferase genes (DNMTs) in the mononuclear cells (MNCs) from bone marrow of 54 cases with hematopoietic malignances were detected by using RT-PCR, Western blot, and methylation-specific PCR. Of the 54 patients, 10 cases were low-risk MDS, 10 cases were high-risk MDS, 10 cases were acute myeloid leukemia (AML), 10 cases were acute lymphocytic leukemia (ALL), 10 cases were chronic myeloid leukemia in chronic phase (CML-CP), and 4 cases were CML in blast phase (CML-BP). 10 normal persons were studied as nective controls. The results showed that the incidence of p15INK4B methylation in cells of high-risk MDS was higher than that in low-risk MDS (6/10 VS 1/10, P=0.003), and the p15INK4B methylation was found to be associated with the down-regulation of the expressions of p15INK4B gene on both mRNA (r=−0.734, p<0.001) and protein (r=−0.664, p=0.001)levels, which indicated that the silencing of p15INK4B gene was in conjunction with hypermethylation in MDS. The expressions of p15INK4B on mRNA level and protein levels were almost detected in the MNCs from bone marrow of normal persons without the p15INK4B methylation. We also found the expression of DNMT3A and DNMT3B in high-risk MDS (densitometry readings respectively: 0.624±0.146, 0.577±0.344) were higher than in low-risk MDS (densitometry readings respectively: 0.487±0.300, 0.338±0.290) (P<0.05). The expression of DNMT1 was higher in the groups of low-risk MDS, high-risk MDS, AL and CML-CP( densitometry readings respectively: 0.487±0.218, 0.697±0.243, 0.706±0.463 and 0.867±0.375) than in normal control (densitometry reading: 0.181±0.312)(P<0.05, figure listed bellow), which indicated that up-regulated DNMTS might contribute to the hypermethylation of p15INK4B, and the higher expressions of de novo methyltransferases DNMT3A and DNMT3B may be related to the disease progression of MDS. The methylation of p15INK4B was also detected in 9/20 of AL cases accompanied by over-expressions of DNMT1, DNMT3A, and DNMT3B (densitometry readings respectively: 0.706±0.463, 1.066±0.547, and 0.530±0.428). The methylation of p15INK4B was detected in 1 of 10 cases of CML-CP patients, but all be detected in 4 case of CML-BP patients. These results indicated that the hypermethylation of p15INK4B gene may be one of the most common genetic event in pathogenesis of high-risk MDS, acute leukemia, and blast phase of CML. Furthermore, DNMT3A and DNMT3B were substantially over-expressed in the bone marrow cells of these patients. which might play an important role in the transformation from MDS to acute leukemia.

Hypermethylation in SFRP2 promoter in human leukemia K562 cells and bone marrow specimen with chronic myeloid leukemia

Study on Methylation of P15ink4b Gene and Its Mechanisms in Patients with Myelodysplastic Syndrome and Leukemia.

The Methylation Pattern of LRP15 Gene in Acute Leukemia

Hypermethylation of secreted frizzled-related proteins predicts poor prognosis in non-M3 acute myeloid leukemia.

Methylation Analysis of the Wnt Antagonist in Myelodysplastic Syndrome

The expression and promoter methylation of SLIT2 gene in human primary hepatocellular carcinomas

The Gene Methylation and Protein Expression of SFRP5 in Leukemic Ceils

Aberrant methylation of secreted frizzled-related protein genes in tissues of colorectal cancer and cancer cell lines

Transcriptional Inactivation of Secreted Frizzled-Related Protein 1 by Promoter Hypermethylation As a Potential Biomarker for Non-Small Cell Lung Cancer.

Hypermethylation and Expression Regulation of Secreted Frizzled-Related Protein Genes in Colorectal Tumor

Frequent epigenetic inactivation of secreted frizzled-related protein 2 (SFRP2) by promoter methylation in human gastric cancer

Methylation of Gene CHFR Promoter in Acute Leukemia Cells

Study of the effect of sFRP1 protein on molecules involved in the regulation of DNA methylation in CML cell line

Expression of TFPI-2 Gene and Its Promoter Methylation in Acute Myeloid Leukemia

Hypermethylation of secreted frizzled related protein 2 gene promoter serves as a noninvasive biomarker for HBV-associated hepatocellular carcinoma

Secreted Frizzled-Related Protein Promotors Are Hypermethylated in Cutaneous Squamous Carcinoma Compared with Normal Epidermis.

Hypermethylation of SFRP2 As a Potential Marker for Stool-Based Detection of Colorectal Cancer and Precancerous Lesions

A Novel Method of Microarray Quantitave Analysis of P16 CPG Island Methylation in Leukemia Cells from Patients with Hematological Malignancies.

Methylation of Wnt antagonist genes: a useful prognostic marker for myelodysplastic syndrome

Changes of NF-κB Expression after Promoter Demethylation of TMS1 in K562 Cells

Clinical and prognostic significance of ABO promotor methylation level in adult leukemia and myelodydysplastic syndrome